Literature DB >> 6144288

Tardive dyskinesia.

D Tarsy, R J Baldessarini.   

Abstract

Tardive dyskinesia is an involuntary movement disorder associated with the prolonged use of antipsychotic drugs. The estimated prevalence rate is 10-15%. Elderly individuals are at greater risk than those below age 50. Although its cause is unknown, increased sensitivity to dopamine in the basal ganglia may contribute to the pathophysiology. No satisfactory treatment is currently available, restricted indications for chronic antipsychotic drug treatment, but early recognition of tardive dyskinesia, and prompt discontinuation of antipsychotic drugs when appropriate may reduce the incidence of this disorder.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144288     DOI: 10.1146/annurev.me.35.020184.003133

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  12 in total

1.  Withdrawal effects of metoclopramide.

Authors:  A M Noll; D Pinsky
Journal:  West J Med       Date:  1991-06

Review 2.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

3.  Striatal dopamine D2 receptors in tardive dyskinesia: PET study.

Authors:  J Blin; J C Baron; H Cambon; A M Bonnet; B Dubois; C Loc'h; B Mazière; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

4.  Endomorphin-1: induction of motor behavior and lack of receptor desensitization.

Authors:  A Mehta; G Bot; T Reisine; M F Chesselet
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

5.  Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.

Authors:  A Campbell; R J Baldessarini; M H Teicher; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  The effects of electromyographic feedback training on suppression of the oral-lingual movements associated with tardive dyskinesia.

Authors:  R C Fudge; S A Thailer; M Alpert; J Intrator; C E Sison
Journal:  Biofeedback Self Regul       Date:  1991-06

Review 7.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.

Authors:  P De Deurwaèrdere; M F Chesselet
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 9.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

10.  Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.

Authors:  R C Pierce; A J Clemens; L A Shapiro; G V Rebec
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.